Author
Listed:
- Arunraj Dhamodaran
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
T-knife Therapeutics, Inc.
German Cancer Research Center in the Helmholtz Association (DKFZ))
- Xiaojing Chen
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC))
- Niklas Fellmer
(T-knife Therapeutics, Inc.)
- Deepti Agrawal
(T-knife Therapeutics, Inc.)
- Eric Danner
(T-knife Therapeutics, Inc.)
- Ralf Kühn
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC))
- Thomas Blankenstein
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC))
Abstract
T cell receptor (TCR) gene therapy is an effective cancer treatment. Ideally, the TCR should be of human origin and have optimal avidity, e.g., isolated from a tumor antigen-non-tolerant host. Previously, we developed ABab-A2 mice which carry human TCRα and TCRβ gene loci and the human leukocyte antigen class I gene HLA-A*02:01 and are deficient for the corresponding mouse genes. Into these mice, we here introduce by PiggyBac transposon HLA-A*03:01, -A*11:01, -B*07:02, -B*15:01, -C*04:01, and -C*07:02 genes. These mice, termed ABab-I, exhibit increased peripheral CD8+ T cell counts and a higher CD8/CD4 ratio compared to ABab-A2 mice. ABab-I mice display a broader TCR repertoire with more unique V(D)J-TCRß clonotypes than ABab-A2 mice. Multi-HLA-I expression selected, on average, TCR with longer complementary determining region 3 (CDR3) compared to expression of a single HLA-I. ABab-I mice mount robust immune responses against viral, tumor-associated, and tumor-specific antigens. ABab-I mice allow simultaneous epitope and TCR discovery with broad HLA coverage, which could increase the number of cancer patients amenable to TCR-T treatments.
Suggested Citation
Arunraj Dhamodaran & Xiaojing Chen & Niklas Fellmer & Deepti Agrawal & Eric Danner & Ralf Kühn & Thomas Blankenstein, 2025.
"Mice with a diverse human T cell receptor repertoire selected on multiple HLA class I molecules,"
Nature Communications, Nature, vol. 16(1), pages 1-18, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61306-y
DOI: 10.1038/s41467-025-61306-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61306-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.